134 related articles for article (PubMed ID: 9106773)
1. Cardiac 18F-FDG-SPET studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping.
Bax JJ; Visser FC; Raymakers PG; Van Lingen A; Cornel JH; Huitink JM; Elhendy A; Heine RJ; Visser CA
Nucl Med Commun; 1997 Mar; 18(3):200-6. PubMed ID: 9106773
[TBL] [Abstract][Full Text] [Related]
2. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols.
Bax JJ; Veening MA; Visser FC; van Lingen A; Heine RJ; Cornel JH; Visser CA
Eur J Nucl Med; 1997 Jan; 24(1):35-41. PubMed ID: 9044874
[TBL] [Abstract][Full Text] [Related]
3. Feasibility, safety and image quality of cardiac FDG studies during hyperinsulinaemic-euglycaemic clamping.
Bax JJ; Visser FC; Poldermans D; van Lingen A; Elhendy A; Boersma E; Visser CA
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):452-7. PubMed ID: 11914881
[TBL] [Abstract][Full Text] [Related]
4. Combined hyperinsulinaemic glucose clamp and oral acipimox for optimizing metabolic conditions during 18F-fluorodeoxyglucose gated PET cardiac imaging: comparative results.
Schröder O; Hör G; Hertel A; Baum RP
Nucl Med Commun; 1998 Sep; 19(9):867-74. PubMed ID: 10581593
[TBL] [Abstract][Full Text] [Related]
5. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of assessing regional myocardial uptake of 18F-fluorodeoxyglucose using single photon emission computed tomography.
Bax JJ; Visser FC; van Lingen A; Huitink JM; Kamp O; van Leeuwen GR; Visser GW; Teule GJ; Visser CA
Eur Heart J; 1993 Dec; 14(12):1675-82. PubMed ID: 8131767
[TBL] [Abstract][Full Text] [Related]
7. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography.
Stoll HP; Hellwig N; Alexander C; Ozbek C; Schieffer H; Oberhausen E
Eur J Nucl Med; 1994 Oct; 21(10):1085-93. PubMed ID: 7828618
[TBL] [Abstract][Full Text] [Related]
8. Relation between myocardial uptake of thallium-201 chloride and fluorine-18 fluorodeoxyglucose imaged with single-photon emission tomography in normal individuals.
Bax JJ; Visser FC; van Lingen A; Groeneveld AB; Huitink JM; Teule GJ; Visser CA
Eur J Nucl Med; 1995 Jan; 22(1):56-60. PubMed ID: 7698156
[TBL] [Abstract][Full Text] [Related]
9. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
Brink I; Nitzsche EU; Mix M; Schindler T; Hentschel M; Högerle S; Moser E
Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
[TBL] [Abstract][Full Text] [Related]
10. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
[TBL] [Abstract][Full Text] [Related]
11. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.
Ohtake T; Yokoyama I; Watanabe T; Momose T; Serezawa T; Nishikawa J; Sasaki Y
J Nucl Med; 1995 Mar; 36(3):456-63. PubMed ID: 7884509
[TBL] [Abstract][Full Text] [Related]
12. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
Knuuti MJ; Saraste M; Nuutila P; Härkönen R; Wegelius U; Haapanen A; Bergman J; Haaparanta M; Savunen T; Voipio-Pulkki LM
Am Heart J; 1994 Apr; 127(4 Pt 1):785-96. PubMed ID: 8154416
[TBL] [Abstract][Full Text] [Related]
13. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.
Lucignani G; Paolini G; Landoni C; Zuccari M; Paganelli G; Galli L; Di Credico G; Vanoli G; Rossetti C; Mariani MA
Eur J Nucl Med; 1992; 19(10):874-81. PubMed ID: 1451704
[TBL] [Abstract][Full Text] [Related]
14. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
[TBL] [Abstract][Full Text] [Related]
15. Influence of high and low plasma insulin levels on the uptake of fluorine-18 fluorodeoxyglucose in myocardium and femoral muscle, assessed by planar imaging.
Huitink JM; Visser FC; van Leeuwen GR; van Lingen A; Bax JJ; Heine RJ; Teule GJ; Visser CA
Eur J Nucl Med; 1995 Oct; 22(10):1141-8. PubMed ID: 8542898
[TBL] [Abstract][Full Text] [Related]
16. A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography.
Martin WH; Jones RC; Delbeke D; Sandler MP
Eur J Nucl Med; 1997 Oct; 24(10):1291-7. PubMed ID: 9323271
[TBL] [Abstract][Full Text] [Related]
17. Low-dose dobutamine stress gated SPET for identification of viable myocardium: comparison with stress-rest perfusion SPET and PET.
Yoshinaga K; Katoh C; Noriyasu K; Yamada S; Ito Y; Kuge Y; Kawai Y; Kohya T; Kitabatake A; Tamaki N
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):882-90. PubMed ID: 12111128
[TBL] [Abstract][Full Text] [Related]
18. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.
Yokoyama I; Ohtake T; Momomura S; Yonekura K; Yamada N; Nishikawa J; Sasaki Y; Omata M
J Nucl Med; 1998 May; 39(5):884-9. PubMed ID: 9591594
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability.
Gerber BL; Ordoubadi FF; Wijns W; Vanoverschelde JL; Knuuti MJ; Janier M; Melon P; Blanksma PK; Bol A; Bax JJ; Melin JA; Camici PG
Eur Heart J; 2001 Sep; 22(18):1691-701. PubMed ID: 11511119
[TBL] [Abstract][Full Text] [Related]
20. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
